Israel’s KoVax has developed a “KV3” vaccine, which helps prevent Koi Herpes Virus, a highly contagious disease that can cause significant mortality in common carp farms. KoVax has just been acquired by Phibro Animal Health Corporation in New Jersey but continues its Israeli R&D.